Argyriou AA, Mitsikostas D, Mantovani E, Litsardopoulos P, Panagiotopoulos V, Tamburin S. An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management. Expert Rev Neurother. 2021;21(4):475–90. https://doi.org/10.1080/14737175.2021.1900734.

Article  CAS  PubMed  Google Scholar 

Gobel H. The international classification of headache disorders. ICHD-3 Web site. https://ichd-3.org/. Updated 2023. Accessed 2 Aug 2023.

Ashina H, Eigenbrodt AK, Seifert T, et al. Post-traumatic headache attributed to traumatic brain injury: classification, clinical characteristics, and treatment. Lancet Neurol. 2021;20(6):460–9. https://doi.org/10.1016/S1474-4422(21)00094-6.

Article  PubMed  Google Scholar 

Ashina H, Iljazi A, Al-Khazali HM, et al. Persistent post-traumatic headache attributed to mild traumatic brain injury: deep phenotyping and treatment patterns. Cephalalgia. 2020;40(6):554–64. https://doi.org/10.1177/0333102420909865.

Article  PubMed  Google Scholar 

McGeary DD, Resick PA, Penzien DB, et al. Reason to doubt the ICHD-3 7-day inclusion criterion for mild TBI-related posttraumatic headache: a nested cohort study. Cephalalgia. 2020;40(11):1155–67. https://doi.org/10.1177/0333102420953109.

Article  PubMed  Google Scholar 

Larsen EL, Ashina H, Iljazi A, et al. Acute and preventive pharmacological treatment of post-traumatic headache: a systematic review. J Headache Pain. 2019;20(1):98–107. https://doi.org/10.1186/s10194-019-1051-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang AR, Calandra MJ, Friedman BW. Clinical predictors of poor 30-day headache outcomes after an emergency department visit for acute post-traumatic headache. Am J Emerg Med. 2021;49:158–62. https://doi.org/10.1016/j.ajem.2021.05.075.

Article  CAS  PubMed  Google Scholar 

Friedman BW, Irizarry E, Cain D, et al. Randomized study of metoclopramide plus diphenhydramine for acute posttraumatic headache. Neurology. 2021;96(18):e2323–31. https://doi.org/10.1212/WNL.0000000000011822.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nicolas S, Nicolas D. Triptans. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. http://www.ncbi.nlm.nih.gov/books/NBK554507/. Accessed 2 Aug 2023.

Cushman DM, Borowski L, Hansen C, Hendrick J, Bushman T, Teramoto M. Gabapentin and tricyclics in the treatment of post-concussive headache, a retrospective cohort study. Headache. 2019;59(3):371–82. https://doi.org/10.1111/head.13451. Accessed 2 Aug 2023.

Article  PubMed  Google Scholar 

Erickson JC. Treatment outcomes of chronic post-traumatic headaches after mild head trauma in US soldiers: an observational study. Headache. 2011;51(6):932–44. https://doi.org/10.1111/j.1526-4610.2011.01909.x.

Article  PubMed  Google Scholar 

Pringsheim T, Davenport W, Mackie G, et al. Canadian headache society guideline for migraine prophylaxis. Can J Neurol Sci. 2012;39(2 Suppl 2):1. https://doi.org/10.1017/S0317167100015109.

Article  Google Scholar 

Boal AH, Smith DJ, McCallum L, et al. Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders. Hypertension. 2016;68(5):1132–8. https://doi.org/10.1161/HYPERTENSIONAHA.116.08188.

Article  CAS  PubMed  Google Scholar 

Ashina H, Al-Khazali HM, Iljazi A, et al. Psychiatric and cognitive comorbidities of persistent post-traumatic headache attributed to mild traumatic brain injury. J Headache Pain. 2021;22(1):83. https://doi.org/10.1186/s10194-021-01287-7.

Article  PubMed  PubMed Central  Google Scholar 

Mayer CL, Savage PJ, Engle CK, et al. Randomized controlled pilot trial of prazosin for prophylaxis of posttraumatic headaches in active-duty service members and veterans. Headache. 2023;63(6):751–62. https://doi.org/10.1111/head.14529. Accessed 14 Nov 2023.

Article  PubMed  Google Scholar 

Mayer, CL. Chronic postconcussive headache: A placebo-controlled treatment trial of prazosin. ClinicalTrials.gov identifier: NCT02266329. Updated 2023. https://www.clinicaltrials.gov/study/NCT02266329?cond=post%20traumatic%20headache&intr=prazosin&rank=2. Accessed 14 Nov 2023.

Raskind, MA. Prazosin for post-concussive headaches. ClinicalTrials.gov identifier: NCT02965027. Updated 2023.https://www.clinicaltrials.gov/study/NCT02965027?cond=post%20traumatic%20headache&intr=prazosin&rank=1. Accessed 14 Nov 2023.

Ashina H, Iljazi A, Al-Khazali HM, et al. Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: An open-label study. J Headache Pain. 2020;21(1):62. https://doi.org/10.1186/s10194-020-01136-z. Accessed 2 Aug 2023.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashina H, Dodick DW. Post-traumatic headache: Pharmacologic management and targeting CGRP signaling. Curr Neurol Neurosci Rep. 2022;22(2):105–11. https://doi.org/10.1007/s11910-022-01175-w. Accessed 2 Aug 2023.

Article  PubMed  Google Scholar 

Ashina H, Iljazi A, Al-Khazali HM, et al. Hypersensitivity to calcitonin gene-related peptide in post-traumatic headache. Ann Neurol. 2020;88(6):1220–8. https://doi.org/10.1002/ana.25915. Accessed 14 Nov 2023.

Article  CAS  PubMed  Google Scholar 

Spierings ELH, Silberstein S, Najib U, et al. A phase 2 study of fremanezumab as a treatment for posttraumatic headache in adult patients (1588). Neurology. 2021;96(15 Supplement). https://n.neurology.org/content/96/15_Supplement/1588. Accessed 14 Nov 2023.

Becker WJ. Botulinum toxin in the treatment of headache. Toxins (Basel). 2020;12(12):803. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766412/. Accessed 14 Nov 2023.

Zirovich MD, Pangarkar SS, Manh C, et al. Botulinum toxin type A for the treatment of post-traumatic headache: a randomized, placebo-controlled, cross-over study. Mil Med. 2021;186(5–6):493–9. https://doi.org/10.1093/milmed/usaa391.

Article  PubMed  Google Scholar 

Dieterich M, Brandt T. The bilateral central vestibular system: Its pathways, functions, and disorders. Ann N Y Acad Sci. 2015;1343:10–26. https://doi.org/10.1111/nyas.12585. Accessed 14 Nov 2023.

Article  PubMed  Google Scholar 

Brandt T, Dieterich M. The dizzy patient: Don’t forget disorders of the central vestibular system. Nat Rev Neurol. 2017;13(6):352–62. https://doi.org/10.1038/nrneurol.2017.58. Accessed 14 Nov 2023.

Article  PubMed  Google Scholar 

Alhilali LM, Yaeger K, Collins M, Fakhran S. Detection of central white matter injury underlying vestibulopathy after mild traumatic brain injury. Radiology. 2014;272(1):224–32. https://doi.org/10.1148/radiol.14132670. Accessed 14 Nov 2023.

Article  PubMed  Google Scholar 

Calzolari E, Chepisheva M, Smith RM, et al. Vestibular agnosia in traumatic brain injury and its link to imbalance. Brain. 2021;144(1):128–43. https://doi.org/10.1093/brain/awaa386. Accessed 14 Nov 2023.

Article  PubMed  Google Scholar 

Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992;32(6):300–4. https://doi.org/10.1111/j.1526-4610.1992.hed3206300.x. Accessed 14 Nov 2023.

Article  CAS  PubMed  Google Scholar 

Liu F, Ma T, Che X, Wang Q, Yu S. The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol. 2017;8:524. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641552/. Accessed 14 Nov 2023.

Lahmann C, Henningsen P, Brandt T, et al. Psychiatric comorbidity and psychosocial impairment among patients with vertigo and dizziness. J Neurol Neurosurg Psychiatry. 2015;86(3):302–8. https://doi.org/10.1136/jnnp-2014-307601. Accessed 14 Nov 2023.

Article  PubMed  Google Scholar 

Ahn S, Balaban CD. Distribution of 5-ht1b and 5-ht1d receptors in the inner ear. Brain Res. 2010;1346:92–101. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903653/. Accessed 14 Nov 2023.

Espinosa-Sanchez JM, Lopez-Escamez JA. New insights into pathophysiology of vestibular migraine. Front Neurol. 2015;6:12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319397/. Accessed 14 Nov 2023.

Fraser F, Matsuzawa Y, Lee YSC, Minen M. Behavioral treatments for post-traumatic headache. Curr Pain Headache Rep. 2017;21(5):22. https://doi.org/10.1007/s11916-017-0624-x.

Article  PubMed  Google Scholar 

McGeary DD, Resick PA, Penzien DB, et al. Cognitive behavioral therapy for veterans with comorbid posttraumatic headache and posttraumatic stress disorder symptoms: A randomized clinical trial. JAMA Neurol. 2022;79(8):746–57. https://doi.org/10.1001/jamaneurol.2022.1567.

Article  PubMed  PubMed Central  Google Scholar 

Mollica A, Greben R, Oriuwa C, Siddiqi S, Burke MJ. Neuromodulation treatments for mild traumatic brain injury and post-concussive symptoms | SpringerLink. Curr Neurol Neurosci Rep. 2022;22:171–181. https://link.springer.com/article/10.1007/s11910-022-01183-w#ref-CR24. Accessed 2 Aug 2023.

Leung A, Shirvalkar P, Chen R, et al. Transcranial magnetic stimulation for pain, headache, and comorbid depression: INS-NANS expert consensus panel review and recommendation. Neuromodulation. 2020;23(3):267–90. https://doi.org/10.1111/ner.13094. Accessed 2 Aug 2023.

Article  PubMed  Google Scholar 

Stilling J, Paxman E, Mercier L, et al. Treatment of persistent post-traumatic headache and post-concussion symptoms using repetitive transcranial magnetic stimulation: a pilot, double-blind, randomized controlled trial. J Neurotrama. 2020;37(2):217–429. https://www.liebertpub.com/doi/epub/10.1089/neu.2019.6692. Accessed 2 Aug 2023.

Leung A, Metzger-Smith V, He Y, et al. Left dorsolateral prefrontal cortex rTMS in alleviating MTBI related headaches and depressive symptoms. Neuromodulation. 2018;21(4):390–401. https://doi.org/10.1111/ner.12615.

Article  PubMed  Google Scholar 

Leung A, Shukla S, Fallah A, et al. Repetitive transcranial magnetic stimulation in managing mild traumatic brain injury-related headaches. Neuromodulation. 2016;19(2):133–41. https://doi.org/10.1111/ner.12364.

Article  PubMed  Google Scholar